What did @trtover40 actually say?
The creator describes a "honeymoon period" in early TRT where patients feel unusually good because their natural testosterone plus exogenous testosterone creates a temporarily elevated androgen load. He lists specific benefits he experienced: sharper cognition, better training recovery, higher libido, more drive, and improved mood. He closes by saying these effects "settle" into a stable foundation rather than disappearing.
This is a personal-experience framing, not a clinical claim, which matters for how we evaluate it. He is not selling a protocol or a dose. He is describing a phenomenological arc that many men on TRT report. The question is whether the mechanism he proposes, the overlap of endogenous and exogenous testosterone, actually holds up.
Does the science back this up?
Partially. The "honeymoon" observation is real and documented, but the mechanism he describes is oversimplified and, in most cases, physiologically incorrect.
When exogenous testosterone is introduced, the hypothalamic-pituitary-gonadal axis detects rising androgen levels and suppresses LH and FSH relatively quickly, typically within days to a couple of weeks depending on the ester and dose (Bhasin et al., 2010, New England Journal of Medicine). This means endogenous testosterone production drops off faster than the creator implies, so the "double load" window is narrow at best.
What is better supported is that mood and energy improvements in hypogonadal men can appear early, sometimes within days, while other effects like muscle composition changes take months (Zitzmann, 2009, Nature Reviews Urology). A 2016 paper by Snyder et al. in the New England Journal of Medicine found sexual function and mood improved at three months in men with low testosterone, consistent with the timeline described here.
What did they get wrong (or right)?
The mechanism claim is the weak link. Saying men feel great early because they have "natural testosterone plus the testosterone you're introducing" is plausible for a very brief window but misrepresents how HPG axis suppression works. Most men on standard TRT protocols see endogenous production suppressed before they even notice the first psychological benefits. The honeymoon feeling is more likely explained by supraphysiological or high-normal testosterone levels from the dosing curve of injectable esters, not a genuine additive overlap of two independent sources.
What he got right is the phenomenology. The list he gives, clarity, energy, libido, confidence, reduced psychological noise, maps closely onto what the research describes for hypogonadal men achieving normal testosterone levels. The Testosterone Trials (Snyder et al., 2016, NEJM) documented improvements across sexual function, mood, and physical capacity in older hypogonadal men that match his description closely. His framing that effects "settle" rather than disappear is also consistent with clinical observation. The euphoric edge fades; the baseline improvement tends to persist.
What should you actually know?
The honeymoon phase is real, but the reason for it matters clinically. If you understand that it is driven by the pharmacokinetics of the ester and HPG suppression, not an additive bonus from two testosterone sources, you will have more realistic expectations when levels stabilize.
A few things worth knowing if you are considering TRT. First, early improvements in mood and libido do not guarantee those effects persist at the same intensity. Second, HPG axis suppression means fertility is affected quickly and may not recover without additional interventions like HCG or FSH. Third, the psychological benefits he describes are most reliably documented in men with confirmed hypogonadism, not in men with low-normal testosterone seeking optimization. Self-diagnosing a "testosterone problem" from mood symptoms alone is not sufficient clinical grounds for treatment.
FormBlends does not recommend specific doses or protocols. Any decision about TRT should involve confirmed lab values, clinical evaluation, and a licensed prescriber.